MDRNA have 36 kinase related RNAi patents published

MDRNA have had 78 RNAi PCT patents published this week including 36 patents aimed at kinases and kinase receptors
See kinasecentral.com for a list of MDRNA kinase related patents

Merck Serono submit Erbitux for NSCLC in Europe

Merck Serono has submitted an EMEA application for Erbitux (cetuximab) for use in the firstline treatment of epidermal growth factor receptor (EGFR) expressing, advanced or metastatic non-small cell lung cancer (NSCLC).

Kemia publish series of alpha ketomide p38 kinase inhibitors

Kemia have published a series of “Reverse” α-ketoamide based p38 MAP kinase inhibitors

Kyowa Hakko publish series of FLT3 inhibitors

Kyowa Hakko have published a series of FLT3 inhibitors

Wistar Inst publish discovery of BRAF inhibitors

Researchers at the Wistar Inst have published research detailing the discovery of purine-2,6-dione BRAF protein kinase inhibitors

Wyeth publish series of PKCtheta inhibitors

Wyeth have published a series of PKC theta (PKCθ) inhibitors with potential in the treatment of asthma